LLY and SNY Related Headlines
Go Back- FDA delays reviews of Sanofi's Tzield and Disc Medicine's bitopertin
- Vida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven Strategy
- M. Stanley cuts Novo Nordisk to Underweight on ’tough path ahead’, shares slip

